Kyowa Kirin funds innovative research, education, and advocacy initiatives in rare hematologic cancers (including CTCL) and bone/mineral diseases to improve patient outcomes and community impact.
Funder: Kyowa Kirin
Due Dates: June 15, 2026 (full proposal submission deadline)
Funding Amounts: $5,000–$100,000 per project; support may be milestone-based
Summary: Supports independent research, education, and patient advocacy initiatives in rare hematologic cancers (including CTCL) and bone/mineral diseases, emphasizing innovation and community impact.
Key Information: Proposals must be submitted at least 90 days before the project start date and align with Kyowa Kirin's areas of interest.
Kyowa Kirin provides grants to support independent research, continuing medical education (CME), and patient empowerment programs that align with their mission to improve outcomes for patients, families, and medical professionals. Current opportunities include the CME Grant for Education on Cutaneous T-Cell Lymphoma (CTCL), as well as broader grants for rare hematologic cancers and bone/mineral diseases. Funded activities may include educational programs, fellowships, research projects, patient/disease registries, investigator-sponsored research, and community or advocacy initiatives, with a focus on innovative approaches and measurable impact.